Six biological aging clocks measuring the body in completely different ways have converged on one molecule. In a new 52-week randomized trial, the AI-designed lung fibrosis drug rentosertib slowed biological aging by roughly 8 months to 4.5 years depending on which biological aging clock you read, in patients with idiopathic pulmonary fibrosis. The convergence is […]